Value Investing /r/SecurityAnalysis NYC Meetup Survey |
- /r/SecurityAnalysis NYC Meetup Survey
- The worst, most unsafe, and most common passwords used by users
- M&A small cap - PACB & ILMN
| /r/SecurityAnalysis NYC Meetup Survey Posted: 24 Apr 2019 05:51 PM PDT /r/SecurityAnalysis NYC Meetup Survey After posting the other day about looking for NYC meetups, it looks like there is interest to put something together for the subreddit. I made a short survey to see what day works best to accommodate the most amount of people. The survey should only take a minute to fill out. Let me know if you are having any problems accessing the survey. Edit 1: If anyone has a good idea for a venue just fill it out in the survey, leave a comment, or send me a private message. [link] [comments]  |
| The worst, most unsafe, and most common passwords used by users Posted: 25 Apr 2019 04:01 AM PDT |
| Posted: 24 Apr 2019 08:03 AM PDT I'm not an MA guy, though I have invested in a few deals in the past and so far no blow ups. I was recently looking at PACB and ILMN, which is an all cash deal and currently giving a 7.8% return which could come in as little as 6 months. PACB is a small cap, biotech stock so I am not sure if the spread is high bc its sorta normal for biotech or if there is some risk I dont see with the FTC. Any thoughts about the deal and what information to look at. Also any tips on MA investing in general are appreciated From PACB's latest 10K On November 1, 2018, we entered into an Agreement and Plan of Merger with Illumina, Inc. ("Illumina") and FC Ops Corp., a whollyowned subsidiary of Illumina (the "Merger Agreement") pursuant to which Illumina will acquire us for $8.00 per share of our common stock in an all-cash transaction and FC Ops Corp. will be merged with and into us (the "Merger"), with us surviving the Merger and becoming a whollyowned subsidiary of Illumina. Completion of the transaction is subject to terms and conditions set forth in the Merger Agreement, including expiration or termination of any waiting periods applicable to the consummation of the Merger under the United States Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and clearance under the antitrust laws of certain non-United States jurisdictions. At a Special Meeting of Stockholders held on January 24, 2019, our stockholders, among other things, approved the adoption of the Merger Agreement. We and Illumina have each received a request for additional information and documentary material, commonly referred to as a "second request," from the United States Federal Trade Commission (the "FTC") in connection with the Merger. The FTC's "second request" has the effect of extending the waiting period applicable to the consummation of the Merger until the 30th day after substantial compliance by us and Illumina with the "second request," unless the waiting period is extended voluntarily by the parties or terminated sooner by the FTC. The parties have entered into a timing agreement with the FTC that extends the waiting period of the "second request" to mid-2019. We and Illumina continue to expect the Merger to be completed in mid-2019, at which time we will become a wholly-owned subsidiary of Illumina and will cease to be a publicly-traded company. No assurance can be given that the required regulatory approvals will be obtained or that the required conditions to closing will be satisfied, and, even if all such approvals are obtained and the conditions are satisfied, no assurance can be given as to the terms, conditions and timing of the approvals. For more information about the effects of our agreement to be acquired by Illumina please see Item 1A Risk Factors under the section "Risks Related to Our Business". [link] [comments]  |
| You are subscribed to email updates from Value Investing. To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google, 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States | |
No comments:
Post a Comment